Clinical Trial Update: Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on imiquimod 5% cream for external genital or perianal warts in HIV-positive patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Warts

Drugs mentioned

• Imiquimod 5% cream (Imiquimod)

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Warts | Phase 4 | Status: COMPLETED